Vemurafenib: First-in-Class BRAF-Mutated Inhibitor for the Treatment of Unresectable or Metastatic Melanoma
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Harborside Press
2015
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4677808/ |